ENTRY       D00435                      Drug
NAME        Nevirapine (JAN/USP/INN);
            Viramune (TN)
  ABBR      NVP
PRODUCT     VIRAMUNE (Boehringer Ingelheim Pharmaceuticals)
  GENERIC   NEVIRAPINE (Amneal Pharmaceuticals LLC)
            NEVIRAPINE (Aurobindo Pharma Limited)
            NEVIRAPINE (Aurobindo Pharma Limited)
            NEVIRAPINE (Camber Pharmaceuticals)
            NEVIRAPINE (Macleods Pharmaceuticals Limited)
            NEVIRAPINE (Macleods Pharmaceuticals Limited)
            NEVIRAPINE (Micro Labs Limited)
            NEVIRAPINE (Mylan Pharmaceuticals)
            NEVIRAPINE (Mylan Pharmaceuticals)
            NEVIRAPINE (Strides Pharma Science Limited)
FORMULA     C15H14N4O
EXACT_MASS  266.1168
MOL_WEIGHT  266.2979
CLASS       Antiviral
             DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)
             DG03107  Anti-HIV agent
              DG01656  HIV reverse transcriptase inhibitor
            Metabolizing enzyme substrate
             DG02919  CYP2B6 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07263
            Therapeutic category: 6250
            ATC code: J05AG01
            Product: D00435<JP/US>
EFFICACY    Antiviral, Reverse transcriptase inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2B6 [HSA:1555], CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07053  Anti-HIV agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AG Non-nucleoside reverse transcriptase inhibitors
                 J05AG01 Nevirapine
                  D00435  Nevirapine (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
               Nevirapine
                D00435  Nevirapine (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D00435  Nevirapine (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)
               D00435  Nevirapine
              DG03107  Anti-HIV agent
               DG01656  HIV reverse transcriptase inhibitor
                D00435  Nevirapine
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               D00435  Nevirapine
              DG01644  CYP2D6 substrate
               D00435  Nevirapine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00435  Nevirapine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D00435  Nevirapine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D00435  Nevirapine (JAN/USP/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D00435  Nevirapine (JAN/USP/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00435
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00435
DBLINKS     CAS: 129618-40-2
            PubChem: 7847501
            ChEBI: 63613
            PDB-CCD: NVP
            LigandBox: D00435
            NIKKAJI: J420.601K
ATOM        20
            1   C5x C    16.4500  -10.0100
            2   C8y C    15.6100   -8.8900
            3   C8y C    15.9600   -7.5600
            4   N1y N    17.2200   -7.0000
            5   N1x N    17.8500  -10.0100
            6   C8y C    18.4800   -7.6300
            7   C8y C    18.7600   -8.9600
            8   N5x N    14.9100   -6.5800
            9   C8x C    13.5800   -7.0000
            10  C8x C    13.2300   -8.3300
            11  C8x C    14.2800   -9.3100
            12  C8y C    20.0900   -9.3800
            13  C8x C    21.1400   -8.4700
            14  C8x C    20.8600   -7.0700
            15  N5x N    19.5300   -6.6500
            16  O5x O    15.8200  -11.2700
            17  C1y C    17.2200   -5.6000
            18  C1a C    20.3700  -10.7800
            19  C1x C    17.9200   -4.4100
            20  C1x C    16.5200   -4.4100
BOND        23
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18    1  16 2
            19    4  17 1
            20   12  18 1
            21   19  20 1
            22   20  17 1
            23   17  19 1
///
